Page 84 - GALENIKA MEDICAL JOURNAL

Literatura

1. Hench PS, Kendal EC et al. The effect of a hormone of the adrenal
cortex (17-hydroxy-11-dehydrocorticosterone; compound E)
and of pituitary adrenocorticotropic hormone on rheumatoid
arthritis. Proc Staff Meet Mayo Clin. 1949 Apr 13;24(8):181-97.
2. Stewart PM. The adrenal cortex. In: Kronenberg HM, Melmed S,
Polonsky KS, Larsen RP, editors. Williams textbook of endocrinology.
11th ed. Philadelphia, PA:Saunders; 2008. Chapter 14.
3. Roubille C, Richer V, Starnino T, McCourt C, McFarlane A,
Fleming P, et al. The effects of tumour necrosis factor inhibitors,
methotrexate, non-steroidal anti-inflammatory drugs and
corticosteroids on cardiovascular events in rheumatoid
arthritis, psoriasis and psoriatic arthritis: a systematic review
and meta-analysis. Ann Rheum Dis. 2015 Mar;74(3):480-9.
4. Buttgereit F, Mehta D, Kirwan J, Szechinski J, Boers M,
Alten RE, et al. Low-dose prednisone chronotherapy
for rheumatoid arthritis: a randomised clinical trial
(CAPRA-2). Ann Rheum Dis. 2013 Feb;72(2):204-10.
5. van Tuyl LH, Boers M, Lems WF, Landewé RB, Han H, van
der Linden S, et al. Survival, comorbidities and joint damage
11 years after the COBRA combination therapy trial in early
rheumatoid arthritis. Ann Rheum Dis. 2010 May;69(5):807-12.
6. Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou
K, Dougados M, et al. EULAR recommendations for the
management of rheumatoid arthritis with synthetic and
biological disease-modifying antirheumatic drugs: 2016
update. Ann Rheum Dis. 2017 Jun;76(6):960-77.

Konflikt interesa: Nema
Primljeno: 05. 03. 2022.
Prihvaćeno: 29. 04. 2022.
Onlajn: 30. 06. 2022.

84 DOI: 10.5937/Galmed2202081B